Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion type Assertion NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_head.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion description "[The study aims to map plasma gelsolin (pGSN) levels in diabetic humans and mice models of type II diabetes and to evaluate the efficacy of gelsolin therapy in improvement of diabetes in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_provenance.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion evidence source_evidence_literature NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_provenance.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion SIO_000772 25478578 NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_provenance.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion wasDerivedFrom befree-2016 NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_provenance.
- NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_assertion wasGeneratedBy ECO_0000203 NP1245124.RA_eoyf7YvWh61u6ZMuxZTHoSd-xdvFOsAGVim_STakO0130_provenance.